Bibliografía del artículo
1. Paula CR. Candidíases. In: Zaitz C, Campbell I, Marques SA et al. Compêndio de Micologia Médica. 1.ed. Medsi, 1998:99-107.
2. Rex JH, Walsh TJ, Sobel JD et al. Practice guidelines for the treatment of candidiasis. J Infect Dis 2000; 30:662-678.
3. Houang ETS, Chu KC, Koehler AP, Cheng AFB. Use of Chromagar Candida for genital specimens in the diagnostic laboratory. J Clin Pathol 1997; 50(7):563-565.
4. Ambler JE, Kerawala M, Yaneza A, Drabu YJ. Evaluation of Chromagar Candida for rapid idenfication and Etest for antifungal susceptibility testing in a district general hospital laboratory. J Clin Pathol 2001; 54(2):158-159.
5. Yocesoy M, Marol S. Performance of Chromagar Candida and BIGGY Agar for presumptive identification of yeasts. Clin Microbiol Infect 2003; 9:253.
6. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M27-A. Wayne, Pa: NCCLS; 1995.
7. Li J, Nong H, Nong D, Cheng L. Study on susceptibility test of pathogenic fungi from otorhinolaryngology by Etest method. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2001; 15 (2):77-79.
8. Matar M, Ostrosky-Zeichner L, Paetznick VL et al. Correlation between Etest, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother 2003; 47 (5):1647-1951.
9. Morace G, Amato G, Bistoni F et al. Multicenter comparative evaluation of six commercial systems and the National Committee for clinical laboratory standards M27-A broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol 2002; 40(8):2953-2958.
10. Lacaz CS. Técnicas micológicas e imunológicas. Técnicas de coloração em micologia. Micopatologia. Meios de cultivo. Preparo de antígenos micóticos. Métodos bioquímicos e imunoquímicos para os estudo de antígenos fúngicos. Prova de PCR. In: Lacaz CS, Porto E, Marins JEC et al. Tratado de Micologia Médica Lacaz. 9ª ed. São Paulo, Sarvier, 2002:918-990.
11. Lacaz CS. Drogas antifúngicas. Terapêutica das micoses. Provas de susceptibilidade in vitro. Dosagem sanguínea. In: Lacaz CS, Porto E, Marins JEC et al. Tratado de Micologia Médica Lacaz. 9ª ed. São Paulo, Sarvier, 2002:998-1067.
12. Daniel CRI, Gupta AK, Daniel MP et al. Candida infection of the nail: role of Candida as a primary or secondary pathogen. Dermatology 1998; 37(12):904-907.
13. Sant’ Ana PL, Milan EP, Martinez R et al. Multicenter Brazilian study of oral Candida species isolated from Aids patients. Mem Inst Oswaldo Cruz, Rio de Janeiro, 2002; 97(2):253-257.
14. Dorko E, Jautová J. Candida species isolated in skin infections. J Eur Acad Dermatol Venereol 2002; 16:234.
15. Coleman DC, Rinaldi MG, Haynes KA et al. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med Mycol 1998; 36:156-165.